Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208806 · ClinicalTrials.gov registry record
Resynchronization Therapy in Young Patients With and Without CHD
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 50
- Enrollment target
NCT00208806 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 50 participants.
The verdict
NCT00208806 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Pacemakers can be attached to one or more than one of the heart chambers. After watching pacemakers work over time, doctors have found that the pacemakers that stimulate only one chamber of the heart sometimes lead to problems later. These problems may be changes in the size and shape of the heart. The heart cannot work as well when some of these changes happen. We need to learn more about these changes and how to prevent them. There has not been an easy way to do this. A new treatment called Cardiac Resynchronization Therapy (CRT) is associated with biventricular pacing where two chambers of the heart are stimulated simultaneously. Tissue Doppler Imaging,Tissue Synchronization Imaging and 3 dimensional echocardiography are new forms of technology that look at the heart while it works. They are similar to a moving x-ray that can watch the heart muscles moving. The movement can be measured. Doctors will check for changes that happen over time. This has not been studied in children before because this kind of is new to this group of patients. This technology is noninvasive which means it can be done from the outside of the body and is painless. The hearts of children grow fast. It is important to be able to know if the pacemaker or problems from dilated cardiomyopathy are causing any changes in the heart that might cause problems. We expect to be able to use information we learn from this study to improve how we use pacemakers in the future to avoid problems that can happen over time.
Interventions
- OTHER congestive heart failure patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208806
The ClinicalTrials.gov registry entry for NCT00208806 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which congestive heart failure patients is the first listed.
NCT00208806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208806 about?
NCT00208806 is a clinical study titled "Resynchronization Therapy in Young Patients With and Without CHD". Pacemakers can be attached to one or more than one of the heart chambers. After watching pacemakers work over time, doctors have found that the pacemakers that stimulate only one chamber of the heart sometimes lead to problems later. These problems may be changes in the size and shape of the heart. ...
What is the current status of trial NCT00208806?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2004-06. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00208806?
The interventions under investigation include: congestive heart failure patients (OTHER).
Who is sponsoring clinical trial NCT00208806?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.